CARDIAC REGENERATION TECHNOLOGIES
CRT is a privately held medical device company based out of Woodstock, Georgia. CRT focuses its efforts on the use of pressure pulse technology and therapy on cardiovascular conditions. CRT designed and developed its patent pending CardioGold pressure pulse device and underlying patented direct epicardial therapy over a four year period commencing in 2006. Pressure pulse therapy has been clinically proven to regenerate and heal damaged soft tissue by causing angiogenesis (increased blood supply), stimulating the migration of progenitor stem cells, and stimulating the in growth of healthy nerves and blood vessels.
CARDIAC REGENERATION TECHNOLOGIES
Industry:
Health Care Medical Medical Device
Address:
Woodstock, Georgia, United States
Country:
United States
Status:
Active
Similar Organizations
Alphatec Spine - international distribution channel
Alphatec Spine - international distribution channel is a global medical device
Apeliotus Technologies
Apeliotus Technologies operates in the Medical Research business.
Coastal Life Technologies
Coastal Life Technologies is a maker of surgical devices.
Evasc Neurovascular Enterprises
Evasc Neurovascular is a privately held medical device company
IMBiotechnologies Ltd
IMBiotechnologies is a privately held Canadian medical device company.
Medivative Technologies
Medivative Technologies is a medical devices company offering the medical device.
Perimeter Medical Imaging
Perimeter Medical Imaging is a medical technology company.
More informations about "Cardiac Regeneration Technologies"
Next generation of heart regenerative therapies: progress and โฆ
Jun 1, 2021 The adult heart is a vital and highly specialized organ of the human body, with limited capability of self-repair and regeneration in case of injury or disease. Engineering โฆSee details»
Translational Cardiovascular Regenerative Technologies
The concept of regenerative approaches comprising of cell-based therapies and cardiovascular tissue engineering technologies and hybrid solutions represents a promising, next generation โฆSee details»
Next generation of heart regenerative therapies: progress and โฆ
Cardiac tissues can be fabricated by joint gelation of cells and a polymer 160 or by having a casting mold to confine the cells in a given polymeric organization 63,90. Typically, natural โฆSee details»
The Long and Winding Road to Cardiac Regeneration - MDPI
Aug 20, 2023 This review offers a comprehensive overview of current advancements and strategies in cardiac regeneration, with a specific focus on regenerative medicine and tissue โฆSee details»
Myocardial Regeneration: Feasible or Fantasy? | Circulation
Jul 29, 2024 Heart regeneration is the holy grail of cardiology. Despite the therapeutic benefits of lipid-lowering drugs, ฮฒ-blockers, antihypertensives, and other medications, heart failure โฆSee details»
Cardiac regeneration โ Past advancements, current โฆ
May 8, 2023 Cardiac regenerative strategies include cell-based therapeutics, gene therapy, direct reprogramming of non-cardiac cells, acellular biologics, and tissue engineering methods to restore damaged hearts. Significant โฆSee details»
Heart regeneration: 20 years of progress and renewed โฆ
Feb 28, 2022 Cardiovascular disease remains the leading cause of death worldwide due in part to the limited capacity of the adult mammalian heart to regenerate (Roth et al., 2020).The heart is the first organ formed during โฆSee details»
Heart Regeneration by Endogenous Stem Cells and โฆ
Jul 20, 2020 Ischemic heart disease is the leading cause of death worldwide. Myocardial infarction results in an irreversible loss of cardiomyocytes with subsequent adverse remodeling and heart failure. Identifying new sources for โฆSee details»
Basic and Translational Research in Cardiac Repair and โฆ
A .gov website belongs to an official government organization in the United States . Secure .gov websites use HTTPS ... On the other hand, advances in HLA-matching, gene editing โฆSee details»
Advancing cardiac regeneration through 3D bioprinting: methods ...
Nov 9, 2023 This article comprehensively reviews the current landscape of 3D bioprinting technology in the realm of cardiac tissue regeneration, encapsulating pivotal methodologies, โฆSee details»
Cardiac regeneration strategies: Staying young at heart | Science
Jun 9, 2017 Yet, the field of cardiac regeneration has experienced a watershed momentโmany or most now believe that latent regeneration machinery can be awakened even in adult โฆSee details»
Cardiac Regeneration: the Heart of the Issue | Current โฆ
Mar 23, 2021 Cardiac regeneration can be obtained by at least two strategies: the first is direct to generate an ex vivo functional myocardial tissue that replaces damaged tissue; the second โฆSee details»
Mechanisms of Cardiac Repair and Regeneration
Apr 13, 2018 Cardiovascular regenerative therapies are pursued on both basic and translational levels. Although efficacy and value of cell therapy for myocardial regeneration can be debated, โฆSee details»
Cardiac regeneration: current therapiesโfuture concepts - PMC
A different strategy for cardiac regeneration by adult stem cells is the mobilization of progenitor cells from ... A couple of challenges remain before these technologies can be translated โฆSee details»
Heart regeneration: 20 years of progress and renewed optimism
Feb 28, 2022 While irreversible scar formation appears to be detrimental to cardiac regeneration (as discussed further in medaka and mammals below), transient fibrosis appears necessary โฆSee details»
Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem โฆ
Oct 21, 2016 Stem cell technology is undoubtedly the most attractive approach for the generation of cardiac tissue and has been moved towards the use of PSCs in the last few โฆSee details»
Advanced Technologies to Target Cardiac Cell Fate Plasticity for โฆ
The multiple cell cultures of cardiac microvascular ECs together with human CFs in the formation of cardiac spheroids also resulted in an increased maturation of hiPSC-CMs, as demonstrated โฆSee details»
Cardiac Regeneration | Circulation Research - AHA/ASA Journals
Mar 17, 2017 Murine cardiac regeneration capacity remains robust into the first postnatal week of life, as hearts injured by apical resection on postnatal day 1 efficiently replenish the lost โฆSee details»
Organoid bioprinting: from cells to functional tissues
1 day ago Integrating bioprinting with organoid technology can enhance tissue engineering by improving complexity, reproducibility and scalability. This Review discusses living materials in โฆSee details»
Abstract 17122: Human iPS Cell-derived 3D Engineered Cardiac โฆ
Nov 6, 2015 Background: Three-dimensional (3D) engineered cardiac tissues (ECTs) are a robust platform technology to investigate cardiovascular (CV) cell function and provide an โฆSee details»